BIOMAT Database Logo BIOMAT Database Logo

Transfer factor as a probe in the immune defect in lepromatous leprosy. 1978

R C Hastings

UI MeSH Term Description Entries
D007918 Leprosy A chronic granulomatous infection caused by MYCOBACTERIUM LEPRAE. The granulomatous lesions are manifested in the skin, the mucous membranes, and the peripheral nerves. Two polar or principal types are lepromatous and tuberculoid. Hansen's Disease,Hansen Disease
D005796 Genes A category of nucleic acid sequences that function as units of heredity and which code for the basic instructions for the development, reproduction, and maintenance of organisms. Cistron,Gene,Genetic Materials,Cistrons,Genetic Material,Material, Genetic,Materials, Genetic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014165 Transfer Factor Factor derived from leukocyte lysates of immune donors which can transfer both local and systemic cellular immunity to nonimmune recipients. Dialyzable Leukocyte Extract,Extract, Dialyzable Leukocyte,Factor, Transfer,Leukocyte Extract, Dialyzable

Related Publications

R C Hastings
Cellular immune defect in lepromatous leprosy.
April 1973, Ethiopian medical journal,
R C Hastings
Transfer factor and lepromatous leprosy.
April 1973, The New England journal of medicine,
R C Hastings
An evaluation of transfer factor as immunotherapy for patients with lepromatous leprosy.
November 1972, The New England journal of medicine,
R C Hastings
A placebo controlled clinical trial of transfer factor in lepromatous leprosy.
January 1979, Clinical and experimental immunology,
R C Hastings
The lepromatous macrophage defect as related to vaccine development in leprosy.
January 1976, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association,
R C Hastings
Passive transfer of immunity in lepromatous leprosy patients by Lawrence's transfer factor.
May 1976, Journal of the Indian Medical Association,
R C Hastings
The Armadillo Factor: Lepromatous Leprosy.
October 2017, The American journal of medicine,
R C Hastings
Circulating immune complexes in lepromatous leprosy.
November 1972, Lancet (London, England),
R C Hastings
[Circulating immune complexes in lepromatous leprosy patients].
May 1983, Vestnik dermatologii i venerologii,
R C Hastings
UVB susceptibility as a risk factor to the development of lepromatous leprosy.
January 2010, Anais brasileiros de dermatologia,
Copied contents to your clipboard!